NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
Spirit AeroSystems Holdings Inc., up $1.80 to $39.94.
The Biden administration is providing $482 million to aviation industry manufacturers to help avert job or pay cuts in the pandemic.
Itamar Medical Ltd., up $9.61 to $30.25.
Zoll Medical is buying the medical device and digital health company for $538 million.
Regenxbio Inc., up $10.32 to $43.40.
The biotechnology company is collaborating with AbbVie on eye-condition treatments.
Dynavax Technologies Corp., down $2.81 to $14.74.
Britain canceled an order for 100 million doses of COVID-19 vaccine from the biotechnology company's partner Valneva.
TransUnion, down $2.52 to $120.71.
The credit reporting company is buying data services company Neustar for $3.1 billion.
Hess Corp. up $3.62 to $71.39.
Oil and gas prices rose and helped lift energy company stocks.
Dexcom Inc., down $8.95 to $540.43.
Chief operating officer Quentin Blackford is resigning.
Canadian Pacific Railway Ltd., up 1 cent to $68.55.
Kansas City Southern has accepted a $31 billion buyout bid from the railroad.
Before you consider Kansas City Southern, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kansas City Southern wasn't on the list.
While Kansas City Southern currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
